News

Search:
 Search

Latest News Regulatory Update | 24 January 2013

Brazil Drops International GMP Inspection Proposal

0 Likes

The Board of Brazil's national regulatory agency, Anvisa, has abandoned a draft resolution that proposed how the regulatory agency would conduct overseas current good manufacturing practice (CGMP) Read More...


Latest News | 13 December 2012

NICE Announces Appointment of New Chairman

0 Likes

The UK's National Institute for Health and Clinical Excellence (NICE) has confirmed David Haslam, a distinguished advisor to several governmental organizations, as the new chairman of the agency, Read More...


Regulatory Update | 11 June 2012

Brazil: Meeting to Discuss New Criteria for Therapeutic Indications

0 Likes

The Board of Anvisa, the national regulatory authority of Brazil, is scheduled to review new regulations governing the format of “non-print” instructions for use of health products and the criteria Read More...


Regulatory Update | 30 April 2012

Brazil: New Board Procedures Established For Oral Arguments

0 Likes

Major changes to the way ANVISA Board meetings are run were published on 25 April (Ordinance 616/2012). Companies in the regulated sector will now have two ways to comment during the open phase of the Read More...


Latest News | 16 April 2012

Eli Lilly's Lechleiter Replaces Sanofi's Veibacher as PhRMA Chairman

0 Likes

The Pharmaceutical Researchers and Manufactuers of America (PhRMA), the powerful trade organization of the pharmaceutical industry, announced at its annual meeting its members have elected John C. Read More...


Regulatory Update | 9 April 2012

Anvisa Reorganization Published

0 Likes

The reorganization of Brazil’s national agency, Anvisa, was officially unveiled in the Official Gazette and defines those responsible for the new organization.CEO Dirceu Barbano will head the Board of Read More...


RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

New Regulatory Focus Apps for iPad and iPhone